160 related articles for article (PubMed ID: 23255846)
1. Candidates for tumor markers of cervical cancer discovered by proteomic analysis.
Song JY; Bae HS; Koo do H; Lee JK; Jung HH; Lee KW; Lee NW
J Korean Med Sci; 2012 Dec; 27(12):1479-85. PubMed ID: 23255846
[TBL] [Abstract][Full Text] [Related]
2. Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
Zhao Q; He Y; Wang XL; Zhang YX; Wu YM
Clin Transl Oncol; 2015 Aug; 17(8):620-31. PubMed ID: 25893434
[TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancer.
Zou S; Shen Q; Hua Y; Jiang W; Zhang W; Zhu X
Reprod Sci; 2013 Nov; 20(11):1356-64. PubMed ID: 23599374
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of progressive factors in uterine cervical cancer.
Choi YP; Kang S; Hong S; Xie X; Cho NH
Proteomics; 2005 Apr; 5(6):1481-93. PubMed ID: 15838902
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of differentially-expressed proteins in squamous cervical cancer.
Zhu X; Lv J; Yu L; Zhu X; Wu J; Zou S; Jiang S
Gynecol Oncol; 2009 Jan; 112(1):248-56. PubMed ID: 19007971
[TBL] [Abstract][Full Text] [Related]
6. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients.
Bae SM; Lee CH; Cho YL; Nam KH; Kim YW; Kim CK; Han BD; Lee YJ; Chun HJ; Ahn WS
Gynecol Oncol; 2005 Oct; 99(1):26-35. PubMed ID: 16051329
[TBL] [Abstract][Full Text] [Related]
7. Protein expression patterns in primary carcinoma of the vagina.
Hellman K; Alaiya AA; Schedvins K; Steinberg W; Hellström AC; Auer G
Br J Cancer; 2004 Jul; 91(2):319-26. PubMed ID: 15199389
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand.
Chanthammachat P; Promwikorn W; Pruegsanusak K; Roytrakul S; Srisomsap C; Chokchaichamnankit D; Svasti J; Boonyaphiphat P; K S; Thongsuksai P
Arch Oral Biol; 2013 Nov; 58(11):1677-85. PubMed ID: 24112734
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
10. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.
Zhu H; Pei HP; Zeng S; Chen J; Shen LF; Zhong MZ; Yao RJ; Shen H
J Proteome Res; 2009 Aug; 8(8):3969-76. PubMed ID: 19507834
[TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics.
Wang W; Jia HL; Huang JM; Liang YC; Tan H; Geng HZ; Guo LY; Yao SZ
Br J Cancer; 2014 Apr; 110(7):1748-58. PubMed ID: 24569473
[TBL] [Abstract][Full Text] [Related]
12. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY
J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111
[TBL] [Abstract][Full Text] [Related]
13. Hox B4 as potential marker of non-differentiated cells in human cervical cancer cells.
Barba-de la Rosa AP; Briones-Cerecero E; Lugo-Melchor O; De León-Rodríguez A; Santos L; Castelo-Ruelas J; Valdivia A; Piña P; Chagolla-López A; Hernandez-Cueto D; Mantilla A; Lazos-Ochoa M; Gonzalez-Yebra B; Salcedo M
J Cancer Res Clin Oncol; 2012 Feb; 138(2):293-300. PubMed ID: 22120585
[TBL] [Abstract][Full Text] [Related]
14. Protein profiling and identification of modulators regulated by human papillomavirus 16 E7 oncogene in HaCaT keratinocytes by proteomics.
Lee KA; Kang JW; Shim JH; Kho CW; Park SG; Lee HG; Paik SG; Lim JS; Yoon DY
Gynecol Oncol; 2005 Oct; 99(1):142-52. PubMed ID: 16038965
[TBL] [Abstract][Full Text] [Related]
15. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.
Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J
Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513
[TBL] [Abstract][Full Text] [Related]
16. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
17. Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomics.
Lee KA; Shim JH; Kho CW; Park SG; Park BC; Kim JW; Lim JS; Choe YK; Paik SG; Yoon DY
Proteomics; 2004 Mar; 4(3):839-48. PubMed ID: 14997504
[TBL] [Abstract][Full Text] [Related]
18. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
Zhang LY; Ying WT; Mao YS; He HZ; Liu Y; Wang HX; Liu F; Wang K; Zhang DC; Wang Y; Wu M; Qian XH; Zhao XH
World J Gastroenterol; 2003 Apr; 9(4):650-4. PubMed ID: 12679903
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
20. Proteomics analysis of stage-specific proteins expressed in human squamous cell lung carcinoma tissues.
Deng B; Ye N; Luo G; Chen X; Wang Y
Cancer Biomark; 2005; 1(6):279-86. PubMed ID: 17192052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
